Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies.

Gallego-Delgado J, Connolly SB, Lázaro A, Sadlier D, Kieran NE, Sugrue DD, Doran P, Brady HR, Osende J, Egido J.

Hypertens Res. 2009 May;32(5):347-57. doi: 10.1038/hr.2009.27. Epub 2009 Mar 27.

PMID:
19325563
2.

MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function.

Lenihan CR, O'Kelly P, Mohan P, Little D, Walshe JJ, Kieran NE, Conlon PJ.

Ren Fail. 2008;30(4):345-52. doi: 10.1080/08860220801947686. Erratum in: Ren Fail. 2018 Nov;40(1):119.

PMID:
18569905
3.

Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury.

Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S, Porter AG, O'Farrelly C, Rabb H, Taylor CT.

FASEB J. 2006 Dec;20(14):2624-6.

PMID:
17142801
4.

Immune responses in kidney preservation and reperfusion injury.

Kieran NE, Rabb H.

J Investig Med. 2004 Jul;52(5):310-4. doi: 10.1136/jim-52-05-30. Review.

PMID:
15551653
5.

Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease.

Kieran NE, Maderna P, Godson C.

Kidney Int. 2004 Apr;65(4):1145-54. Review.

6.

Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy.

Sadlier DM, Connolly SB, Kieran NE, Roxburgh S, Brazil DP, Kairaitis L, Wang Y, Harris DC, Doran P, Brady HR.

J Biol Chem. 2004 Jul 9;279(28):29670-80. Epub 2004 Mar 18.

7.

DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.

Higgins DF, Lappin DW, Kieran NE, Anders HJ, Watson RW, Strutz F, Schlondorff D, Haase VH, Fitzpatrick JM, Godson C, Brady HR.

Kidney Int. 2003 Dec;64(6):2079-91.

8.

Transcriptome profiling and the pathogenesis of diabetic complications.

Connolly SB, Sadlier D, Kieran NE, Doran P, Brady HR.

J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S279-83. Review.

9.

Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog.

Kieran NE, Doran PP, Connolly SB, Greenan MC, Higgins DF, Leonard M, Godson C, Taylor CT, Henger A, Kretzler M, Burne MJ, Rabb H, Brady HR.

Kidney Int. 2003 Aug;64(2):480-92.

Supplemental Content

Loading ...
Support Center